Takeda

News

Mosquito is extracting blood from skin and has turned bright red

Takeda dengue vaccine receives positive CHMP opinion

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion of Takeda GmbH’s live, attenuated dengue tetravalent vaccine, Qdenga

News

Takeda farms out cancer drug alisertib to Puma Biotech

Takeda has decided that there is a future for its aurora kinase A inhibitor alisertib after it failed a phase 3 trial in lymphoma – but the company won't be taking the drug forward itself.<

Views & Analysis

Transforming oncology outcomes through data and digital

The healthcare industry is evolving rapidly, with data and digital technologies transforming everyday communications as we know them.

News

Dengue, zika and chikungunya fever mosquito (aedes aegypti) on human skin

Takeda gets first approval for its dengue vaccine

Japan's Takeda has secured its first regulatory approval – in Indonesia – for its dengue fever vaccine TAK-003, which has been tipped as a potential blockbuster product.

News

CSL preps filings for once-monthly antibody for HAE

Australia's CSL has said its one-monthly treatment for hereditary angioedema has shown it is safe and effective in a phase 3 trial, and will be filed for approval in its current financial y

News

After coeliac fail, 9 Meters plots phase 3 in short bowel sy...

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from a mid-stage trial of its candidate for short bowel syndr

Takeda dengue vaccine receives positive CHMP opinion

Takeda farms out cancer drug alisertib to Puma Biotech

Transforming oncology outcomes through data and digital

Takeda gets first approval for its dengue vaccine

CSL preps filings for once-monthly antibody for HAE

After coeliac fail, 9 Meters plots phase 3 in short bowel sy...

Harnessing the cell's own degradation machinery, with Benedi...

How to meet your physicians where they are online

Takeda

Editor's Picks